159 related articles for article (PubMed ID: 9307247)
1. Calcium channels in neurological disease.
Greenberg DA
Ann Neurol; 1997 Sep; 42(3):275-82. PubMed ID: 9307247
[TBL] [Abstract][Full Text] [Related]
2. Abnormal intracellular ca(2+)homeostasis and disease.
Missiaen L; Robberecht W; van den Bosch L; Callewaert G; Parys JB; Wuytack F; Raeymaekers L; Nilius B; Eggermont J; De Smedt H
Cell Calcium; 2000 Jul; 28(1):1-21. PubMed ID: 10942700
[TBL] [Abstract][Full Text] [Related]
3. [P/Q-type voltage-dependent calcium channels in neurological disease].
Gazulla J; Tintore M
Neurologia; 2007 Oct; 22(8):511-6. PubMed ID: 17573560
[TBL] [Abstract][Full Text] [Related]
4. [Channelopathy].
Okamoto K; Ikeda Y
Rinsho Shinkeigaku; 2001 Dec; 41(12):1226-8. PubMed ID: 12235844
[TBL] [Abstract][Full Text] [Related]
5. Ryanodine receptor 1 mutations, dysregulation of calcium homeostasis and neuromuscular disorders.
Treves S; Anderson AA; Ducreux S; Divet A; Bleunven C; Grasso C; Paesante S; Zorzato F
Neuromuscul Disord; 2005 Oct; 15(9-10):577-87. PubMed ID: 16084090
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis of inherited calcium channelopathies: role of mutations in pore-forming subunits.
McKeown L; Robinson P; Jones OT
Acta Pharmacol Sin; 2006 Jul; 27(7):799-812. PubMed ID: 16787562
[TBL] [Abstract][Full Text] [Related]
7. Ion channels-related diseases.
Dworakowska B; Dołowy K
Acta Biochim Pol; 2000; 47(3):685-703. PubMed ID: 11310970
[TBL] [Abstract][Full Text] [Related]
8. [Intracellular calcium: physiology and physiopathology].
Missiaen L; Callewaert G; Parys JB; Wuytack F; Raeymaekers L; Droogmans G; Nilius B; Eggermont J; De Smedt H
Verh K Acad Geneeskd Belg; 2000; 62(6):471-99. PubMed ID: 11196578
[TBL] [Abstract][Full Text] [Related]
9. The sarcoplasmic reticulum Ca2+ channel/ryanodine receptor: modulation by endogenous effectors, drugs and disease states.
Zucchi R; Ronca-Testoni S
Pharmacol Rev; 1997 Mar; 49(1):1-51. PubMed ID: 9085308
[No Abstract] [Full Text] [Related]
10. Calcium channelopathies in inherited neurological disorders: relevance to drug screening for acquired channel disorders.
Lory P; Mezghrani A
IDrugs; 2010 Jul; 13(7):467-71. PubMed ID: 20582871
[TBL] [Abstract][Full Text] [Related]
11. [Physiopathology of calcium channels: identification of calcium channelopathies].
Lory P; Monteil A
C R Seances Soc Biol Fil; 1998; 192(1):137-47. PubMed ID: 9759359
[TBL] [Abstract][Full Text] [Related]
12. Early onset, non fluctuating spinocerebellar ataxia and a novel missense mutation in CACNA1A gene.
Tonelli A; D'Angelo MG; Salati R; Villa L; Germinasi C; Frattini T; Meola G; Turconi AC; Bresolin N; Bassi MT
J Neurol Sci; 2006 Feb; 241(1-2):13-7. PubMed ID: 16325861
[TBL] [Abstract][Full Text] [Related]
13. Ca2+ channels as targets of neurological disease: Lambert-Eaton Syndrome and other Ca2+ channelopathies.
Flink MT; Atchison WD
J Bioenerg Biomembr; 2003 Dec; 35(6):697-718. PubMed ID: 15000529
[TBL] [Abstract][Full Text] [Related]
14. Migraine, ataxia and epilepsy: a challenging spectrum of genetically determined calcium channelopathies. Dutch Migraine Genetics Research Group.
Terwindt GM; Ophoff RA; Haan J; Sandkuijl LA; Frants RR; Ferrari MD
Eur J Hum Genet; 1998; 6(4):297-307. PubMed ID: 9781035
[TBL] [Abstract][Full Text] [Related]
15. [Channelopathies in neurology].
Grippo J; Grippo T
Rev Neurol; 2001 Oct 1-15; 33(7):643-7. PubMed ID: 11784953
[TBL] [Abstract][Full Text] [Related]
16. Neuromuscular disease and calcium channels.
Greenberg DA
Muscle Nerve; 1999 Oct; 22(10):1341-9. PubMed ID: 10487899
[TBL] [Abstract][Full Text] [Related]
17. Lambert-Eaton myasthenic syndrome: search for alternative autoimmune targets and possible compensatory mechanisms based on presynaptic calcium homeostasis.
Takamori M
J Neuroimmunol; 2008 Sep; 201-202():145-52. PubMed ID: 18653248
[TBL] [Abstract][Full Text] [Related]
18. [Ion channel diseases in neurology].
Lerche H; Mitrovic N; Lehmann-Horn F
Fortschr Neurol Psychiatr; 1997 Nov; 65(11):481-8. PubMed ID: 9480290
[TBL] [Abstract][Full Text] [Related]
19. Expression and cellular localization of a modified type 1 ryanodine receptor and L-type channel proteins in non-muscle cells.
Lee BS; Sessanna S; Laychock SG; Rubin RP
J Membr Biol; 2002 Oct; 189(3):181-90. PubMed ID: 12395283
[TBL] [Abstract][Full Text] [Related]
20. Voltage-gated calcium channels and disease.
Cain SM; Snutch TP
Biofactors; 2011; 37(3):197-205. PubMed ID: 21698699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
